Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,454
Views
27
CrossRef citations to date
0
Altmetric
Coronaviruses

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection

Chaitanya Kurhadea Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAView further author information
,
Jing Zoua Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAView further author information
,
Hongjie Xiaa Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USAView further author information
,
Mingru Liub Department of Pathology, University of Texas Medical Branch, Galveston, TX, USAView further author information
,
Qi Yangc Pfizer Vaccine Research and Development, Pearl River, NY, USAView further author information
,
Mark Cutlerc Pfizer Vaccine Research and Development, Pearl River, NY, USAView further author information
,
David Cooperc Pfizer Vaccine Research and Development, Pearl River, NY, USAView further author information
,
Alexander Muikd BioNTech, Mainz, GermanyView further author information
,
Ugur Sahind BioNTech, Mainz, GermanyView further author information
,
Kathrin U. Jansenc Pfizer Vaccine Research and Development, Pearl River, NY, USAView further author information
,
Ping Renb Department of Pathology, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
View further author information
,
Xuping Xiea Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
View further author information
,
Kena A. Swansonc Pfizer Vaccine Research and Development, Pearl River, NY, USACorrespondence[email protected]
View further author information
&
Pei-Yong Shia Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USACorrespondence[email protected]
View further author information
 show all
Pages 1828-1832 | Received 29 Jun 2022, Accepted 04 Jul 2022, Published online: 27 Jul 2022

References

  • Kurhade C, Zou J, Xia H, et al. Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine. Nat Commun. 2022;13:3602.
  • Xia H, Zou J, Kurhade C, et al. Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2. Cell Host Microbe. 2022;30:485–488.e3.
  • Colson P, Fournier PE, Delerce J, et al. Culture and identification of a “Deltamicron” SARS-CoV-2 in a three cases cluster in southern France. J Med Virol. 2022;94(8):3739–3749.
  • Zou J, Kurhade C, Xia H, et al. Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2. Nat Commun. 2022;13:2956.
  • Lyngse FP, Kirkeby C, Halasa T, et al. Nationwide study on SARS-CoV-2 transmission within households from lockdown to reopening, Denmark, 27 February 2020 to 1 August 2020. Euro Surveill. 2022;27(6):2001800.
  • Peacock TP, Brown JC, Zhou J, et al. The SARS-CoV-2 variant, omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. BioRxiv. 2022. doi:10.1101/2021.12.31.474653
  • Redd AD, Nardin A, Kared H, et al. Minimal crossover between mutations associated with Omicron variant of SARS-CoV-2 and CD8(+) T-cell epitopes identified in COVID-19 convalescent individuals. mBio. 2022;13(2):e03617–21.
  • Falsey AR, Frenck RW, Walsh EE, et al. SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3. N Engl J Med. 2021;385(17):1627–1629.
  • Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589–593.
  • Walsh EE, Frenck RW, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020;383:2439–2450.
  • Liu Y, Liu J, Xia H, et al. Neutralizing activity of BNT162b2-elicited serum. N Engl J Med. 2021;384:1466–1468.
  • Xie X, Muruato A, Lokugamage KG, et al. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe. 2020;27:841–848.e3.
  • Xie X, Liu Y, Liu J, et al. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med. 2021;27:620–621.
  • Xie X, Lokugamage KG, Zhang X, et al. Engineering SARS-CoV-2 using a reverse genetic system. Nat Protoc. 2021;16:1761–1784.
  • Zou J, Xia H, Xie X, et al. Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection. Nat Commun. 2022;13:852.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.